Skip to content
Search
Please enter at least 3 characters.

Latest Stories

GPhC plans to enhance pharmacy inspections with targeted, flexible approach

The General Pharmaceutical Council (GPhC) has announced plans to update the pharmacy inspection process
gettyimages

The pharmacy regulator will conduct shorter, more focused inspections alongside full inspections

The General Pharmaceutical Council (GPhC) has announced plans to update the pharmacy inspection process by adopting a more targeted and flexible approach.

The GPhC inspects registered pharmacies in Great Britain to ensure they meet required standards, assuring patients and the public of safe, effective care.


During its Council meeting today (12), the pharmacy regulator outlined plans to improve its inspection approach, including the introduction of shorter, more focused inspections alongside the existing full inspections, to increase efficiency and enable more inspection activity.

Inspectors can switch to a full inspection if they believe it is necessary or beneficial. Pharmacies being inspected for the first time will automatically undergo a full inspection.

In addition to focused and full inspections, other types, such as re-inspections, intelligence-led inspections, and themed inspections, will also continue.

Roz Gittins, chief pharmacy officer at GPhC, highlighted the importance of pharmacy inspections in ensuring safe and effective pharmacy care, whether online or face-to-face.

“Updating the inspections process means we can be more targeted, focusing on areas of higher risk, and the key standards for patient safety.

“It means we will be able to carry out more inspection activity as efficiently as possible.”

“Our priority is patient safety, and inspections help with assuring the public that they can have trust in pharmacy and the services they provide,” he added.

Proposed changes include:

  • A more targeted inspection approach, focusing on higher-risk areas through shorter, focused inspections for some routine checks.
  • The option to conduct re-inspections up to six months and two weeks from the date of the initial inspection, ensuring timely follow-up when standards are not met.
  • A more flexible, risk-based approach to when and how to carry out inspections for newly-registered pharmacies
  • Shorter, clearer inspection reports and improved standardisation of approach across the inspectorate.

The planned changes are set to be implemented in January 2025.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less